Breakthrough neuroimmunology trials impress at AAN meeting
- PMID: 31114035
- DOI: 10.1038/s41582-019-0206-0
Breakthrough neuroimmunology trials impress at AAN meeting
Comment on
-
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.N Engl J Med. 2019 Aug 15;381(7):614-625. doi: 10.1056/NEJMoa1900866. Epub 2019 May 3. N Engl J Med. 2019. PMID: 31050279 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources